Caffeic acid regulates glucose homeostasis and inhibits purinergic and cholinergic activities while abating oxidative stress and dyslipidaemia in fructose-streptozotocin-induced diabetic rats
- 30 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 74 (7) , 973-984
Abstract
The antidiabetic potential of caffeic acid in fructose/streptozotocin-induced type 2 diabetic rats was examined in this study. Male Sprague-Dawley rats were supplied with 10% fructose solution for 14 days followed by an intraperitoneal injection of 40 mg/kg bw streptozotocin to induce type 2 diabetes (T2D). Rats were treated with both low (150 mg/kg bw) and high (300 mg/kg bw) doses of caffeic acid for 5 weeks, while the positive control group was treated with metformin (200 mg/kg bw). Treatment with caffeic acid significantly decreased blood glucose levels and elevated serum insulin levels while improving glucose tolerance, pancreatic β-cell function and morphology. It also led to a significant reduction of serum cholesterol, triglyceride, LDL-cholesterol, ALT, AST, creatinine, urea and uric acid levels, while increasing HDL cholesterol levels. Caffeic acid significantly (P < 0.05) elevated hepatic glycogen level, serum and pancreatic glutathione level, superoxide dismutase and catalase activities with a concomitant decrease in malondialdehyde level, α-amylase, lipase, adenosine triphosphatase (ATPase), ectonucleoside triphosphate diphosphohydrolase (ENTPDase), 5ʹ-nucleotidase (5ʹ-NTD) and acetylcholinesterase activities. The results suggest caffeic acid as a potent natural product with therapeutic effects against T2D. Further molecular and clinical studies are, however, required to ascertain these findings.Keywords
Funding Information
- National Research Foundation-The World Academy of Science (NRF-TWAS), Pretoria (116106)
This publication has 65 references indexed in Scilit:
- Beta Cell Dysfunction and Insulin ResistanceFrontiers in Endocrinology, 2013
- Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerationsDiabetes, Metabolic Syndrome and Obesity, 2012
- Purinergic signalling in the pancreas in health and diseaseJournal of Endocrinology, 2012
- Effects of the aqueous extract of white tea (Camellia sinensis) in a streptozotocin-induced diabetes model of ratsPhytomedicine, 2011
- Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humansNature Medicine, 2011
- ATP-gated P2X3receptors constitute a positive autocrine signal for insulin release in the human pancreatic β cellProceedings of the National Academy of Sciences, 2010
- Treatment of dyslipidemia in patients with type 2 diabetesLipids in Health and Disease, 2010
- Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expressionCarcinogenesis, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).Journal of Clinical Investigation, 1995